Release
First factor XIa inhibitor nabs FDA approval for stroke prevention
Nature · By Asher Mullard ·
The Brief
- The US FDA has approved the first factor XIa inhibitor.
- The approval is for stroke prevention.
- The news was reported by Nature Reviews Drug Discovery on 11 November 2026.
Why it matters
Factor XIa inhibitors are a new class of anticoagulant, so this first approval marks a new option for stroke prevention that science readers can track.
Who’s affected
- clinicians and stroke patients
- pharmaceutical and anticoagulation researchers
- #factor xia inhibitors
- #stroke prevention
- #anticoagulants
- #fda approval
- #drug approval
Nature Reviews Drug Discovery, Published online: 11 November 2026; doi:10.1038/d41573-026-00180-9 First factor XIa inhibitor nabs FDA approval for stroke prevention